Suchen Sie nach Informationen zu Hauptsitz Von Avila Therapeutics? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


Avila Therapeutics - Crunchbase Company Profile

    https://www.crunchbase.com/organization/avila-therapeutics
    Where is Avila Therapeutics 's headquarters? Avila Therapeutics is located in Waltham, Massachusetts, United States. Who invested in Avila Therapeutics? Avila Therapeutics has 7 investors including Abingworth and Advent Venture Partners. How much funding has Avila Therapeutics raised to date? Avila Therapeutics has raised $59.3M.

Avila Therapeutics - Atlas Venture

    https://atlasventure.com/company/avila-therapeutics
    Avila Therapeutics. In January 2012 Celgene (NASDAQ: CELG) acquired Avila Therapeutics to pursue development of the company’s Btk inhibitor and covalent drug discovery platform. Headquarters. Bedford, MA. Pipeline. Phase 2 Btk program advancing at Celgene.

Avila Therapeutics - Overview, News & Competitors

    https://www.zoominfo.com/c/avila-therapeutics-inc/353934302
    Avila Therapeutics is a clinicalstage biotechnology company focused on the design and development of targeted covalent drugs to achieve bestin class outcomes. T he company's product pipeline has been built using its proprietary Avilomics™ platform and is currently focused on cancer, viral infection and autoimmune disease. Avila's most ...

Avila Therapeutics Company Profile: Acquisition

    https://pitchbook.com/profiles/company/51400-99
    Contact Information Website www.avilatx.com Ownership Status Acquired/Merged Financing Status Formerly VC-backed Primary Industry Pharmaceuticals Acquirer Celgene Primary Office 100 Beaver Street Waltham, MA 02453 United States +1 (781) 000-0000 Want detailed data on 3M+ companies? What you see here scratches the surface Request a free trial

Avila Therapeutics - Contacts, Employees, Board …

    https://www.crunchbase.com/organization/avila-therapeutics/people
    Avila Therapeutics has 2 current employee profiles, including Co-Founder & Chief Scientific Officer Juswinder Singh. Contacts. Edit Contacts Section. We're working on getting contact data for Avila Therapeutics . Find more contact data in Search! Get started . Employee Profiles.

AVILA THERAPEUTICS INC Top 13F Holdings - WhaleWisdom.com

    https://whalewisdom.com/filer/avila-therapeutics-inc
    Avila Therapeutics is based out of Waltham. The firm last filed a Form D notice of exempt offering of securities on 2010-07-06. The notice included securities offered of Equity Summary; 13D/G; Insider (Form 4) Form D 3; Mutual Funds/ETFs; Contact Info. avila ...

Artivila Therapeutics

    http://www.artivila.com/en/founders.html
    Principal Investigator at Avila Therapeutics Principal Scientist at Pfizer Dr. Zhu has over 20-year drug discovery experience, especially in data mining/analysis, AI/ML approach, drug design, cheminformatics and computational chemistry. He was engaged in several innovative drug discovery projects, which successfully advanced to the clinical stage.

Avilar Therapeutics Announces Formation of Scientific Advisory …

    https://avilar-tx.com/news/avilar-therapeutics-announces-formation-of-scientific-advisory-board-with-leading-experts-in-protein-degradation-chemistry-genetics-and-drug-discovery/
    WALTHAM, Mass., May 16, 2022 – Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced the formation of its Scientific Advisory Board (SAB) comprised of an esteemed group of leading scientists with expertise in protein degradation, chemistry, genetics, and drug discovery.

Avilar Therapeutics Company Profile: Valuation

    https://pitchbook.com/profiles/company/458371-27
    Contact Information Website www.avilar-tx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Biotechnology Other Industries Drug Discovery Decision/Risk Analysis Primary Office 400 Totten Pond Road Suite 110 Waltham, MA 02451 United States Avilar Therapeutics Timeline 2021 2022 Financing Round

Avilar Therapeutics to Present at the Guggenheim Targeted …

    https://avilar-tx.com/news/avilar-therapeutics-to-present-at-the-guggenheim-targeted-protein-degrader-day/
    WALTHAM, Mass., March 14, 2022 – Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced that Daniel Grau, CEO and President, will present at the upcoming Guggenheim Targeted Protein Degradation Day at 2:00PM – 2:30PM on Wednesday, March 16, 2022. The format of the day will consist of ...

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Avila Therapeutics gefunden haben.